Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the cage: The rise and promise of non-animal models in biomedical research.

European journal of pharmacology·2026
Same author

Exploring the Immunomodulatory Effects of <i>Agaricus bisporus</i> Strains Using In Vitro and In Vivo Murine Models.

Nutrients·2026
Same author

Safety of a novel oral immunotherapy approach in preschool children with single and multiple food allergies.

Frontiers in allergy·2026
Same author

Gut bacteria composition in animal models of Parkinson's disease: a systematic review and meta-analysis.

NPJ Parkinson's disease·2026
Same author

A Specific Ratio of Dietary Short-Chain and Long-Chain Fructo-Oligosaccharides Shifts the Immune Response Away from Type 2 in a Murine Model for House Dust Mite-Induced Asthma.

Nutrients·2025
Same author

Maternal Cigarette Smoke Exposure Does Not Impair Influenza Vaccine Responsiveness in Murine Offspring.

Vaccines·2025
Same journal

Baicalin downregulates Thromboxane A<sub>2</sub> receptor via SIRT1/NRF2 and NLRP3 pathways to attenuate Cyclosporine A-induced hypertension.

European journal of pharmacology·2026
Same journal

ARBUTIN AS A THERAPEUTIC CANDIDATE FOR AUTISM: CURRENT EVIDENCE AND MECHANISTIC INSIGHTS INTO PI3K/Akt/mTOR and Nrf2 PATHWAYS.

European journal of pharmacology·2026
Same journal

Repeated Ethanol Exposure in Female Rats Impairs Cerebral Endothelial Function and Increases Cerebrovascular Stiffness.

European journal of pharmacology·2026
Same journal

Valerenic acid attenuates chronic stress-exacerbated metabolic dysfunction-associated steatotic liver disease via the estrogen receptor α-GDF15 axis.

European journal of pharmacology·2026
Same journal

Theranekron Prevents Endotoxin-Induced Acute Kidney Injury by Modulating Inflammatory and Mitochondrial Apoptotic Pathways.

European journal of pharmacology·2026
Same journal

Icariside Ⅱ alleviates heart failure based on Wnt/β-catenin-mitochondrial apoptotic pathway.

European journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Fabrication of Dissolvable Microneedle Patches Loaded with &#945;-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
06:33

Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction

Published on: December 30, 2025

Pharma-nutrition interface: the gap is narrowing.

Niki A Georgiou1, Johan Garssen, Renger F Witkamp

  • 1Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands.

European Journal of Pharmacology
|December 1, 2010
PubMed
Summary
This summary is machine-generated.

The synergy between pharmacology and nutrition is growing, offering new strategies for complex diseases. This integrated approach targets multiple pathways for improved health outcomes and reduced drug side effects.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Fabrication of Dissolvable Microneedle Patches Loaded with &#945;-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
06:33

Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction

Published on: December 30, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Integrative biology
  • Nutritional science
  • Pharmacology

Background:

  • Nutritional status significantly impacts health and disease, with lifestyle factors like diet playing a crucial role.
  • A continuum exists between health and disease, necessitating an understanding of gene-environment-homeostasis interactions.
  • The traditional one disease-one target approach is yielding fewer successes for complex, multifactorial conditions.

Purpose of the Study:

  • To explore the increasing synergy between pharmacology and nutrition science.
  • To highlight the shift towards multi-targeting approaches for complex diseases.
  • To review the therapeutic potential of combined food-drug interventions.

Main Methods:

  • Literature review of current research on pharmacology and nutrition interactions.
  • Analysis of therapeutic synergy examples between nutrients and pharmaceuticals.
  • Case study review of conditions like metabolic syndrome, immune-related diseases, and HIV.

Main Results:

  • Nutritional interventions can complement drug therapies by improving patient condition or mitigating side effects.
  • Complex diseases require multi-pathway understanding and combination therapies.
  • Emerging fields like CNS diseases and cancer show promise for increased pharmacological-nutritional synergy.

Conclusions:

  • The integration of pharmacology and nutrition science is essential for addressing complex health challenges.
  • Future therapeutic strategies will likely involve synergistic combinations of drugs and nutrients.
  • This interdisciplinary approach holds significant potential for managing chronic diseases, particularly in an aging population.